Abstract:Dysfunction of late endothelial progenitor cells (EPCs) has been suggested to be associated with hypertension. β2-Adrenergic receptor (β2AR) is a novel and key target for EPC homing. Here, we proposed that attenuated β2AR signaling contributes to EPCs dysfunction, whereas enhanced β2AR signaling restores EPCs' functions in hypertension. EPCs derived from hypertensive patients exhibited reduced cell number, impaired in vitro migratory and adhesion abilities, and impaired re-endothelialization after transplantation in nude mice with carotid artery injury. β2AR expression of EPCs from hypertensive patients was markedly downregulated, whereas the phosphorylation of the p38 mitogen-activated protein kinase (p38-MAPK) was elevated. The cleaved caspase-3 levels were elevated in EPCs. The overexpression of β2AR in EPCs from hypertensive patients inhibited p38-MAPK signaling, whereas it enhanced in vitro EPC proliferation, migration, and adhesion and in vivo re-endothelialization. The β2AR-mediated effects were attenuated by treating the EPCs with a neutralizing monoclonal antibody against β2AR, which could be partially antagonized by the p38-MAPK inhibitor SB203580. Moreover, shear stress stimulation, a classic nonpharmacological intervention, increased the phosphorylation levels of β2AR and enhanced the in vitro and in vivo functions of EPCs from hypertensive patients. Collectively, the current investigation demonstrated that impaired β2AR/p38-MAPK/caspase-3 signaling at least partially reduced the re-endothelialization capacity of EPCs from hypertensive patients. Restoration of β2AR expression and shear stress treatment could improve their endothelial repair capacity by regulating the p38-MAPK/caspase-3 signaling pathway. The clinical significance of β2AR in endothelium repair still requires further investigation.NEW & NOTEWORTHY Impaired β2-adrenergic receptor (β2AR) expression with an elevation of p38-MAPK/caspase-3 signaling at least partially contributes to the decline of re-endothelialization capacity of late endothelial progenitor cells (EPCs) from hypertensive patients. β2AR gene transfer and shear stress treatment improve the late EPC-mediated enhancement of the re-endothelialization capacity in hypertensive patients through activating β2AR/p38-MAPK/caspase-3 signaling. The present study is the first to reveal the potential molecular mechanism of the impaired endothelium-reparative capacity of late EPCs in hypertension after vascular injury and strongly suggests that β2AR is a novel and crucial therapeutic target for increasing EPC-mediated re-endothelialization capacity in hypertension.

Impaired endothelial progenitor cell activity is associated with reduced arterial elasticity in patients with essential hypertension.

Reduced Number and Activity of Circulating Endothelial Progenitor Cells from Patients with Hyperhomocysteinemia.

Impaired Endothelium-dependent Vasodilatation in Different Level of Risk in Essential Hypertension

Number and Activity of Endothelial Progenitor Cells from Peripheral Blood in Patients with Hypercholesterolaemia

Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension.

Impaired Endothelium-dependent Vasodilation and Treatment in Essential Hypertension

Effects of three beta-blockers on vasorelaxation in spontaneously hypertensive rats

Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction

Regular Exercise-Induced Increased Number and Activity of Circulating Endothelial Progenitor Cells Attenuates Age-Related Decline in Arterial Elasticity in Healthy Men.

External Counterpulsation Attenuates Hypertensive Vascular Injury Through Enhancing the Function of Endothelial Progenitor Cells

Effect of Hypertension on the In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells

Higher Numbers of Circulating Endothelial Progenitor Cells Are Associated with Better Functional Performance in Patients with Peripheral Artery Disease

The pathologic mechanism underlying hypertension-induced decline in arterial elasticity

Endothelial progenitor cell impairment mediated vasodilation dysfunction via diminishing nitric oxide production in postmenopausal females

Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells

ASSA13-10-20 Characteristics and Related Risk Factors of Arterial Elasticity in Prehypertensive Persons

Importance of Β2ar Elevation for Re-Endothelialization Capacity Mediated by Late Endothelial Progenitor Cells in Hypertensive Patients.

Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects.

The Relationship of Blood Pressure Level with the Artery Elasticity, AGEs (advanced Glycation End-Products) and Vwf (von Willebrand Factor) Changes in Patients with Essential Hypertension and Coronary Heart Disease

Increased Endothelial Progenitor Cells And Nitric Oxide In Young Prehypertensive Women

152 INCREASED NEOPTERIN LEVEL IS ASSOCIATED WITH IMPAIRED ARTERIAL ELASTICITY IN HYPERTENSIVE PATIENTS